Methscopolamine bromide

Class
Anticholinergics
Subclass
Muscarinic receptor antagonists
Substance name
Methscopolamine bromide
Common formulations
Tablet
Dosage and administration
Adults patients
Adjunctive treatment for peptic ulcer disease
•
2.5 mg PO BID
Other off-label uses
•
Treatment of dumping syndrome
•
Treatment of IBS
Indications for use
Labeled indications
Adults
•
Adjunctive treatment for peptic ulcer disease
Off-label indications
Adults
•
Treatment of dumping syndrome
•
Treatment of IBS
Pregnancy and breastfeeding
Breastfeeding
Acceptable for use during breastfeeding.
•
Long term therapy may have an effect on breastfeeding infants.
Unknown amount excreted in breastmilk.
Unknown drug levels in breastfed infants.
No overt adverse effects on lactation reported.
Adverse reactions
Unknown frequency
•
Anaphylaxis, angioedema, cycloplegia, ↑ intraocular pressure, mydriasis, bloating, blurred vision, constipation, dizziness, dry mouth, headache, insomnia, loss of sweating, nausea, nervousness, palpitations, reduced sense of taste, sexual dysfunction, skin rash, somnolence, urinary retention, vomiting, weakness, tachycardia, urticaria
Interactions
Drug(s)
Check Interactions
Reset

What did you think about this content?

Create free account

Sign up for free to access the full drug resource